Differential influence of vitamin D analogs on left ventricular mass index in maintenance hemodialysis patients

Sezer S., Tutal E., Bal Z., Uyar M. E., Bal U., Cakir Ü., ...Daha Fazla

INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, cilt.37, sa.2, ss.118-125, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 37 Sayı: 2
  • Basım Tarihi: 2014
  • Doi Numarası: 10.5301/ijao.5000289
  • Dergi Adı: INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.118-125
  • Anahtar Kelimeler: Hemodialysis, Secondary hyperparathyroidism, Left ventricular hypertrophy, CARDIOVASCULAR-DISEASE, PARATHYROID-HORMONE, INTESTINAL CALCIUM, DIALYSIS PATIENTS, CALCITRIOL, RISK, PARICALCITOL, CALCIFICATION, PHOSPHORUS
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Purpose: Secondary hyperparathyroidism (SHPT) is a common feature in maintenance hemodialysis (MHD) patients. Inadequate treatment of SHPT has been associated with cardiovascular complications, and vitamin D therapy might influence the development of cardiovascular diseases. In the present study, we aimed to evaluate the effects of intravenous paricalcitol and calcitriol treatments on left ventricular mass index changes in MHD patients.